StonvexLoading…
StonvexStonvexStonvexCore line items from CLOQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $15.00K | $15.99K | $2.67K | $197.00 |
Operating Income | $-752.93K | $-367.25K | $-682.34K | $-1.06M |
Net Income | $-989.45K | $-1.03M | $-979.05K | $-1.09M |
EPS (Diluted) | $-0.01 | $-0.01 | $0.01 | $-0.01 |
Total Assets | $1.84M | $1.46M | $341.12K | $264.50K |
Total Liabilities | $2.83M | $1.02M | $324.13K | $299.53K |
Cash & Equivalents | $282.87K | $307.17K | $4.07K | $54.30K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 128.79M | 122.59M | 119.09M | 82.75M |